openPR Logo
Press release

Alzheimer’s Association Long Island Hosts Inaugural Physician’s Outreach Dinner

03-16-2012 10:29 AM CET | Associations & Organizations

Press release from: Alzheimer's Association Long Island

/ PR Agency: PRMG
On March 7, Alzheimer’s Association Long Island hosted 50 physicians at its first-ever Physician’s Outreach Dinner at the Melville Marriott. Guest speakers included Dr. Peter Davies, Ronda Wexler-Kahn and Mindy Wexler-Rosenfeld, Dr. Norman Pflaster and Ronald Fatoullah.

Dr. Davies, Scientific Director, Litwin-Zucker Center for the Research of Alzheimer’s Disease and Memory Disorders, Feinstein Institute for Medical Research and North Shore LIJ Health Care System, covered treatments and diagnostic testing for the disease. In their presentation, Ms. Wexler-Kahn, RPh, and Ms. Wexler-Rosenfeld, RPh — two New York State-licensed pharmacists specializing in geriatric pharmacy services, drug utilization evaluation and psychiatric medication — showed those in attendance how to describe the Black Box warnings and the quality-of-life issues to their patients and their families and discuss the medication spectrum as it relates to Alzheimer’s disease.

Dr. Pflaster, Assistant Attending Neurologist, Southside Hospital and Attending Neurologist, Brookhaven, Central Suffolk and Southampton Hospitals, described in his presentation the common causes of dementia, the pathophysiology of Alzheimer’s disease, how Alzheimer’s can be managed and how to approach delirium in patients with dementia.

Ms. Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Association Long Island, discussed the community resources provided by the chapter and how physicians can make this information available to their patients and their families. Mr. Fatoullah, Esq., CELA, Member, AALI’s Legal Advisory Board, gave an overview of Medicaid and Veterans Administration benefits and long-term care insurance and how physicians should be able to provide current referrals for Alzheimer’s patients and their caregivers.

An estimated 5.4 million Americans have Alzheimer’s disease, according to the Alzheimer’s Association. Of that number, 5.2 million are 65 years of age and older. That means one in eight people aged 65 and older have Alzheimer’s. On Long Island, 55,000 people have Alzheimer’s. With the growing number of “baby boomers,” Ms. Malack-Ragona says the number of those with Alzheimer’s disease is expected to increase.

For more information about the Alzheimer’s Association, please contact Ms. Malack-Ragona at (631) 820-8068 or visit us at www.alz.org/longisland.

* Photo is available upon request.

About Alzheimer’s Association

The Alzheimer's Association is the world’s leading voluntary health organization in Alzheimer’s care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s. For more information, visit www.alz.org.

Hank Russell, Public Relations Director
The Public Relations and Marketing Group
156 North Ocean Avenue
Patchogue, NY 11772
(631) 207-1057
hrussell@theprmg.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer’s Association Long Island Hosts Inaugural Physician’s Outreach Dinner here

News-ID: 214571 • Views:

More Releases for Alzheimer

Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as